NUE vs EMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 10, 2026
NUE
EMR
Investment Advisor Scores
EMR
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NUE | EMR | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.8866 | 22.779 | NUE |
| PEG Ratio | 5.2129 | 1.8923 | EMR |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 32.0% | 7.1% | NUE |
| Earnings Growth | 120.5% | 18.5% | NUE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.7/100 | 42.5/100 | NUE |
| Profit Margin | 9.3% | 14.2% | EMR |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NUE
NeutralMixed signals - no dominant trend phase, RSI 52
EMR
MarkupPrice above SMA50, rising 50-day trend (1.6% over 20 days), RSI 55
Fundamentals Snapshot
| Metric | NUE | EMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 11.9 | 23.1 |
| Trailing P/E | 16.3 | 35.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.1% |
| Gross Margin | 0.2% | 0.5% |
| Operating Margin | 0.2% | 0.3% |
| EPS | 15.70 | 4.79 |
| Dividend Yield | 0.01% | 0.00% |